With IPO under its belt, important milestones on the horizon for G1 Therapeutics
June 28, 2017 at 14:35 PM EDT
After raising more than $108 million in its initial public offering last month, Research Triangle Park-based G1 Therapeutics is expecting important milestones in 2018.
